Becton, Dickinson and Company (BDX)
NYSE: BDX · Real-Time Price · USD
191.71
+0.45 (0.24%)
Sep 5, 2025, 1:33 PM - Market open
Becton, Dickinson and Company (BDX) Revenue by Segment
History
| Date | Medical | Interventional | Life Sciences |
|---|---|---|---|
| Mar 31, 2025 | 10.77B | 5.02B | 5.14B |
| Dec 31, 2024 | 10.46B | 5.05B | 5.20B |
| Sep 30, 2024 | 10.07B | 4.98B | 5.19B |
| Jun 30, 2024 | 9.79B | 4.92B | 5.18B |
| Mar 31, 2024 | 9.67B | 4.90B | 5.15B |
| Dec 31, 2023 | 9.58B | 4.80B | 5.12B |
| Sep 30, 2023 | 9.50B | 4.74B | 5.13B |
| Jun 30, 2023 | 8.79B | 4.63B | 5.09B |
| Mar 31, 2023 | 8.54B | 4.55B | 5.17B |
| Dec 31, 2022 | 8.60B | 4.48B | 5.38B |
| Sep 30, 2022 | 8.84B | 4.46B | 5.56B |
| Jun 30, 2022 | 9.54B | 4.44B | 5.81B |
| Mar 31, 2022 | 9.72B | 4.38B | 5.93B |
| Dec 31, 2021 | 9.62B | 4.28B | 6.03B |
| Sep 30, 2021 | 9.48B | 4.24B | 6.53B |
| Jun 30, 2021 | 9.26B | -2.89B | 6.49B |
| Mar 31, 2021 | 9.01B | 3.85B | 6.00B |
| Dec 31, 2020 | 8.85B | 3.83B | 5.53B |
| Sep 30, 2020 | 8.68B | 3.76B | 4.68B |
Source: Business metrics provided by Main Street Data and sourced
from official company press releases and documents.